Yeasts
Contents
Follow the Research
| Title | Information |
|---|---|
| Effects of increasing levels of purified beta-1,3/1,6-glucans on the fecal microbiome, digestibility, and immunity variables of healthy adult dogs | At a Glance A 2024 feeding trial in healthy adult dogs tested purified beta-1,3/1,6-glucans sourced from yeast. At a 0.14% inclusion in dry food, dogs showed improved protein digestibility, a microbiome shift toward generally beneficial bacteria, and a small uptick in an immune balance marker, with no adverse clinical effects noted. The authors frame beta-glucans as a family of fibers also found in fungi such as mushrooms, so these yeast results help inform the broader beta-glucan conversation. Connecting the Dots |
| Microbiota in mild inflammatory bowel disease (IBD) can be modulated by beta-glucans and mannanoligosaccharides: A randomized, double-blinded study in dogs | At a Glance This 2024 randomized, double-blinded clinical trial tested daily oral prebiotics in dogs with mild inflammatory bowel disease (IBD), a chronic intestinal condition where the immune system reacts abnormally to food and normal gut bacteria, disturbing the microbiota (“dysbiosis”). Over 60 days on a standardized hypoallergenic diet, beta-glucan supplementation improved bacterial diversity and supported groups often reduced in dysbiosis; adding mannanoligosaccharides (MOS) did not show clear extra benefit. Dogs stayed clinically stable and the products were well tolerated. Connecting the Dots |